SuperworthSkinHealth Systems price to free cash flow SKIN
Market value divided by free cash flow over the last twelve months, since 2023.
- Today, Oct 23, 2026
- 3.3×
- 3-year median
- 6.6×
- Against its 3-year history
- 13th
- percentile: 0 is its lowest day, 100 its highest
- 3-year range
- 2.6× to 176×
- Peer median
- 11.0×
SkinHealth Systems' price to free cash flow is 3.3× as of Oct 23, 2026.
That is below its 3-year median of 6.6×, lower than on 87% of days in the last 3 years.
Over that time it ranged from 2.6× in May 2026 to 176× in Aug 2024.
The median for 10 medical instruments and supplies stocks of a similar size is 11.0×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 3.3× | 2.6× | 5.1× |
| 2025 | 4.8× | 4.2× | 10.8× |
| 2024 | 160× | 12.0× | 176× |
| 2023 | 24.4× | 17.7× | 25.8× |
Against its peers
Companies in Medical - Instruments & Supplies nearest SkinHealth Systems' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| SKINSkinHealth Systems | 3.3× |
| APTAlpha Pro Tech | 9.7× |
| KEQUKewaunee Scientific | 8.7× |
| NEPHNephros | n/m |
| PDEXPro DEX | 29.5× |
| UTMDUtah Medical Products | 20.6× |
| INFUInfuSystem | 12.1× |
| EMBCEmbecta | 2.3× |
| TCMDTactile Systems Technology | 20.0× |
| MDXGMimedx | n/m |
| MOVMovado | 9.8× |
| Peer median | 11.0× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on SkinHealth Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.